VVM
Versant Venture Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-410,360
| Closed | -$9.01M | – | 10 |
|
|
2022
Q1 | $9.01M | Hold |
410,360
| – | – | 8.99% | 4 |
|
|
2021
Q4 | $11.7M | Sell |
410,360
-410,360
| -50% | -$11.7M | 6.24% | 6 |
|
|
2021
Q3 | $17.3M | Hold |
820,720
| – | – | 7.15% | 5 |
|
|
2021
Q2 | $15.5M | Sell |
820,720
-1,209,896
| -60% | -$22.8M | 5.13% | 6 |
|
|
2021
Q1 | $31M | Hold |
2,030,616
| – | – | 6.05% | 6 |
|
|
2020
Q4 | $28.7M | Hold |
2,030,616
| – | – | 2.98% | 7 |
|
|
2020
Q3 | $31.8M | Hold |
2,030,616
| – | – | 5.82% | 5 |
|
|
2020
Q2 | $35.6M | Buy |
+2,030,616
| New | +$35.6M | 5.11% | 5 |
|